 |
 |

Serratia marcescens EndocarditisReport of a Patient
J. Curtis Williams, Jr., MD;
Joseph E. Johnson III, MD
Arch Intern Med. 1970;125(6):1038-1040.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
Serratia marcescens, a member of the gram-negative Enterobacteriaceae (Klebsiella-Enterobacter-Serratia group) has been regarded principally as a benign commensal microorganism of low pathogenicity. In fact, its disease producing potential has been considered so low that it has been used as a "marker" organism in human clinical experiments, the investigators taking advantage of its characteristic bright-red pigmentation for easy identification.1-3 Scattered reports of human disease caused by Serratia have appeared since the report of a chronic, nonfatal pulmonary infection by Woodward and Clarke in 1913.4 Lane reported an instance of agranulocytosis and septicemia which resulted in the first death attributable to S marcescens in 1935.5 In recent years, however, reports of infection with the organism have become more frequent, possibly related to its predilection for producing disease in chronically debilitated patients undergoing complex management.6 Six patients with bacterial endocarditis have been described previously.7-12 A seventh instance, to our knowledge, the first due
. . . [Full Text PDF of this Article]
Author Affiliations
Gainesville, Fla
From the Department of Medicine. University of Florida College of Medicine, Gainesville.
Footnotes
Received for publication July 2, 1969; accepted July 24.
Reprint requests to the J. Hillis Miller Health Center, University of Florida, Gainesville, Fla 32601 (Dr. Johnson).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|